No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Xenco Medical Expands its Ambulatory Surgery Center Device Portfolio with FDA Clearance and Launch of its Multilevel CerviKit

Editor: What To Know

  • Xenco Medical has expanded its ASC surgical device portfolio through the FDA clearance and launch of its Multilevel CerviKitTM, an expansion of Xenco Medical's breakthrough single-use cervical spine technology to include a comprehensive suite of implants and single-use instruments for 2, 3, and 4 level anterior cervical spine procedures.
  • Optimized for the ambulatory surgery center setting, the Multilevel CerviKit builds on Xenco Medical's existing portfolio of disposable spinal implant and instrument platforms included in its ASC CerviKit and adds to its portfolio of single-use lumbar surgical devices.
  • Developed at the intersection of materials science and mechanical engineering, the highly reinforced, composite polymer instruments included with each of Xenco Medical's multilevel anterior cervical plates allow for both consistent mechanical performance and the elimination of the costly logistics associated with the autoclave process.

Xenco Medical has expanded its ASC surgical device portfolio through the FDA clearance and launch of its Multilevel CerviKitTM, an expansion of Xenco Medical’s breakthrough single-use cervical spine technology to include a comprehensive suite of implants and single-use instruments for 2, 3, and 4 level anterior cervical spine procedures.

Optimized for the ambulatory surgery center setting, the Multilevel CerviKit builds on Xenco Medical’s existing portfolio of disposable spinal implant and instrument platforms included in its ASC CerviKit and adds to its portfolio of single-use lumbar surgical devices. The cervical plating options included in the Multilevel CerviKit feature an optimally thin profile, an intuitive locking mechanism, and a dual textured surface for thorough fixation.

The surgical platform is a sterile-packaged, single-use system designed to enhance intraoperative efficiency. Matched with a disposable delivery instrument and coupled with corresponding, single-use surgical instruments, the Multilevel CerviKit is engineered to complement Xenco Medical’s existing portfolio of single-use spinal systems.

Developed at the intersection of materials science and mechanical engineering, the highly reinforced, composite polymer instruments included with each of Xenco Medical’s multilevel anterior cervical plates allow for both consistent mechanical performance and the elimination of the costly logistics associated with the autoclave process. By expanding Xenco Medical’s current ASC portfolio, the Multilevel CerviKit is designed to strengthen an ambulatory surgery center’s ability to overcome sterilization bottlenecks while providing optimal care.

“As COVID-19 spurred increased demand for sterile-packaged, single-use spinal platforms and accelerated growth in the volume of outpatient cervical spine procedures, we have bolstered our commitment to expanding access to safer, streamlined surgical procedures through the launch of our single-use Multilevel CerviKit,” said Xenco Medical Founder and CEO Jason Haider.

Designed to be easily transportable, each Xenco Medical spinal system has been designed for both surgical performance and logistical efficiency. Unlike traditional instruments that are reused in hundreds of patients until a mechanical failure, the disposable Xenco Medical spinal implant systems are optimally calibrated and sterile-packaged for individual use. The product of advanced materials science, Xenco Medical’s single-use spinal implant systems are designed to be compatible with the company’s intelligent surgical vending machines and can be trained on using Xenco Medical’s glasses-free holographic surgical simulation platform.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy